Huang Xiao-Hong, Wang Shui-Yun, Xu Jian-Ping, Song Yun-Hu, Sun Han-Song, Tang Yue, Dong Chao, Yang Yue-Jin, Hu Sheng-Shou
Special Medical Care Centre, Fuwai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences, Beijing, China.
Chin Med J (Engl). 2007 Sep 20;120(18):1563-6.
Myocardial bridging with systolic compression of the left anterior descending coronary artery (LAD) may be associated with myocardial ischaemia. The clinical outcome in patients with surgical treatment for symptomatic myocardial bridging remains undetermined. This study assessed the middle- and long-term results of surgical treatment for symptomatic myocardial bridging.
From 1997 to 2006, 37,463 patients received selective coronary angiography in the Fuwai Cardiovascular Hospital, Beijing, China. Of these, 484 patients had angiographic diagnosis of myocardial bridging. Of the 484 patients, 35 underwent surgery for treatment of myocardial bridging with significant systolic arterial compression. Among the surgical treatment patients, 24 presented with other cardiac disorders, and the remaining 11 symptomatic patients with isolated myocardial bridging were included in the follow-up study.
The angiographic prevalence of myocardial bridging was 1.3% in this study. The coronary angiographies of the 11 patients revealed myocardial bridging in the middle segment of LAD causing systolic compression > or = 75% (ranging from 75% to 90%). The mean age of patients was 48.4 years. Surgical myotomy was performed in 3 patients and coronary artery bypass grafting (CABG) in 8 patients. Eight patients were operated on with an off-pump approach and 3 with a cardiopulmonary bypass technique after median sternotomy. Conversion to on-pump CABG surgery was necessary in 1 patient because of perforation of the right ventricle. The left internal mammary artery was used in all patients with CABG. The acute clinical success rate was 100% with respect to the absence of myocardial infarction, death or other major in-hospital complications. All of the patients were followed up clinically. The median follow-up was 35.3 months (range: 6 to 120 months). Nine patients were free from symptoms and one of them continued taking beta blockers. The remaining 2 patients with myotomy had atypical chest pain. One received coronary angiography again and no stenosis was found two years after operation; while exercise testing was performed in the other patient and revealed no evidence of myocardial ischaemia. None of the patients sustained a myocardial infarction or other major adverse cardiac events (death or vessel revascularization) during follow-up.
Myocardial bridging is a relatively common angiographic finding. Surgical myotomy or CABG should be limited to patients who are refractory to oral medication. Surgical relief of myocardial ischaemia due to systolic compression of intramyocardial coronary arteries can be accomplished with low operative risk and excellent middle- and long-term results.
左前降支冠状动脉(LAD)收缩期受压的心肌桥可能与心肌缺血有关。有症状心肌桥患者手术治疗的临床结果尚不确定。本研究评估了有症状心肌桥手术治疗的中长期结果。
1997年至2006年,中国北京阜外心血管病医院37463例患者接受了选择性冠状动脉造影。其中,484例患者经血管造影诊断为心肌桥。在这484例患者中,35例因严重收缩期动脉受压接受了心肌桥手术治疗。在手术治疗的患者中,24例合并其他心脏疾病,其余11例有症状的孤立性心肌桥患者被纳入随访研究。
本研究中心肌桥的血管造影患病率为1.3%。11例患者的冠状动脉造影显示LAD中段心肌桥导致收缩期受压≥75%(范围为75%至90%)。患者的平均年龄为48.4岁。3例患者行手术心肌切开术,8例患者行冠状动脉旁路移植术(CABG)。8例患者采用非体外循环方法手术,3例患者在正中开胸后采用体外循环技术手术。1例患者因右心室穿孔,需转为体外循环CABG手术。所有CABG患者均使用左乳内动脉。无心肌梗死、死亡或其他主要院内并发症,急性临床成功率为100%。所有患者均进行了临床随访。中位随访时间为35.3个月(范围:6至120个月)。9例患者无症状,其中1例继续服用β受体阻滞剂。其余2例行心肌切开术的患者有非典型胸痛。1例患者术后两年再次接受冠状动脉造影,未发现狭窄;另1例患者进行了运动试验,未发现心肌缺血证据。随访期间无患者发生心肌梗死或其他主要不良心脏事件(死亡或血管再血管化)。
心肌桥是一种相对常见的血管造影表现。手术心肌切开术或CABG应限于对口服药物治疗无效的患者。因心肌内冠状动脉收缩期受压导致的心肌缺血,手术解除可获得低手术风险和良好的中长期结果。